| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,545 |
4,425 |
$240K |
| 87428 |
|
300 |
258 |
$14K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
931 |
644 |
$14K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,883 |
2,327 |
$12K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
829 |
638 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,724 |
597 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,100 |
910 |
$8K |
| J2010 |
Injection, lincomycin hcl, up to 300 mg |
528 |
421 |
$6K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
660 |
525 |
$3K |
| 81001 |
|
645 |
516 |
$1K |
| 81025 |
|
54 |
43 |
$195.16 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
365 |
332 |
$136.74 |
| 87807 |
|
170 |
69 |
$127.32 |
| 3077F |
|
29 |
28 |
$0.00 |
| 82947 |
|
38 |
17 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
23 |
12 |
$0.00 |
| 3080F |
|
34 |
31 |
$0.00 |